Carcinoid heart disease – still a challenging diagnosis?
Neuroendocrine tumors (NETs) are rare neoplasms that can occur anywhere in the body. Mostly, they are located in the gastrointestinal tract or lungs. A third of subjects with NETs present carcinoid syndrome (CS) features. Carcinoid heart disease (CaHD) or Hedinger syndrome is a frequent manifestatio...
Saved in:
| Main Authors: | , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Sciendo
2025-06-01
|
| Series: | Romanian Journal of Cardiology |
| Subjects: | |
| Online Access: | https://doi.org/10.2478/rjc-2025-0013 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1849721576550825984 |
|---|---|
| author | Benchea Laura Cătălina Anghel Larisa Sascău Radu Andy Stătescu Cristian |
| author_facet | Benchea Laura Cătălina Anghel Larisa Sascău Radu Andy Stătescu Cristian |
| author_sort | Benchea Laura Cătălina |
| collection | DOAJ |
| description | Neuroendocrine tumors (NETs) are rare neoplasms that can occur anywhere in the body. Mostly, they are located in the gastrointestinal tract or lungs. A third of subjects with NETs present carcinoid syndrome (CS) features. Carcinoid heart disease (CaHD) or Hedinger syndrome is a frequent manifestation occurring in patients with carcinoid syndrome. Most commonly, it involves the tricuspid and pulmonary valves and represents an independent adverse prognostic factor. We report the case of a 53-year-old woman who presented with increasing dyspnea and fatigue. Her past medical history was remarkable for small intestine neuroendocrine tumors. Transthoracic echocardiography revealed enlarged right cavities with medioventricular trabeculation but normal right ventricle systolic function and severe tricuspid and pulmonic regurgitation. Carcinoid heart disease was confirmed by cardiac magnetic resonance imaging. Management of this patient included somatostatin analogs and heart failure treatment according to current guidelines. We also discuss the indication for surgical treatment. At a three month follow-up, the patient was asymptomatic but needed close imaging supervision. |
| format | Article |
| id | doaj-art-d01d2f01ecd34bc299c35959ee6827d6 |
| institution | DOAJ |
| issn | 2734-6382 |
| language | English |
| publishDate | 2025-06-01 |
| publisher | Sciendo |
| record_format | Article |
| series | Romanian Journal of Cardiology |
| spelling | doaj-art-d01d2f01ecd34bc299c35959ee6827d62025-08-20T03:11:37ZengSciendoRomanian Journal of Cardiology2734-63822025-06-0135213213610.2478/rjc-2025-0013Carcinoid heart disease – still a challenging diagnosis?Benchea Laura Cătălina0Anghel Larisa1Sascău Radu Andy2Stătescu Cristian31Cardiovascular Diseases Institute „Prof. Dr. George I. M. Georgescu”, Iaşi, România Discipline of Cardiology1Cardiovascular Diseases Institute „Prof. Dr. George I. M. Georgescu”, Iaşi, România Discipline of Cardiology1Cardiovascular Diseases Institute „Prof. Dr. George I. M. Georgescu”, Iaşi, România Discipline of Cardiology1Cardiovascular Diseases Institute „Prof. Dr. George I. M. Georgescu”, Iaşi, România Discipline of CardiologyNeuroendocrine tumors (NETs) are rare neoplasms that can occur anywhere in the body. Mostly, they are located in the gastrointestinal tract or lungs. A third of subjects with NETs present carcinoid syndrome (CS) features. Carcinoid heart disease (CaHD) or Hedinger syndrome is a frequent manifestation occurring in patients with carcinoid syndrome. Most commonly, it involves the tricuspid and pulmonary valves and represents an independent adverse prognostic factor. We report the case of a 53-year-old woman who presented with increasing dyspnea and fatigue. Her past medical history was remarkable for small intestine neuroendocrine tumors. Transthoracic echocardiography revealed enlarged right cavities with medioventricular trabeculation but normal right ventricle systolic function and severe tricuspid and pulmonic regurgitation. Carcinoid heart disease was confirmed by cardiac magnetic resonance imaging. Management of this patient included somatostatin analogs and heart failure treatment according to current guidelines. We also discuss the indication for surgical treatment. At a three month follow-up, the patient was asymptomatic but needed close imaging supervision.https://doi.org/10.2478/rjc-2025-0013carcinoid tumorscarcinoid syndromeheartcardiac imagingtumorile carcinoidesindromul carcinoidinimaimagistica cardiacă |
| spellingShingle | Benchea Laura Cătălina Anghel Larisa Sascău Radu Andy Stătescu Cristian Carcinoid heart disease – still a challenging diagnosis? Romanian Journal of Cardiology carcinoid tumors carcinoid syndrome heart cardiac imaging tumorile carcinoide sindromul carcinoid inima imagistica cardiacă |
| title | Carcinoid heart disease – still a challenging diagnosis? |
| title_full | Carcinoid heart disease – still a challenging diagnosis? |
| title_fullStr | Carcinoid heart disease – still a challenging diagnosis? |
| title_full_unstemmed | Carcinoid heart disease – still a challenging diagnosis? |
| title_short | Carcinoid heart disease – still a challenging diagnosis? |
| title_sort | carcinoid heart disease still a challenging diagnosis |
| topic | carcinoid tumors carcinoid syndrome heart cardiac imaging tumorile carcinoide sindromul carcinoid inima imagistica cardiacă |
| url | https://doi.org/10.2478/rjc-2025-0013 |
| work_keys_str_mv | AT benchealauracatalina carcinoidheartdiseasestillachallengingdiagnosis AT anghellarisa carcinoidheartdiseasestillachallengingdiagnosis AT sascauraduandy carcinoidheartdiseasestillachallengingdiagnosis AT statescucristian carcinoidheartdiseasestillachallengingdiagnosis |